Portfolio Companies

BOSTON, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and commercializing novel cance...
Read more

HAMILTON, ON and BOSTON, Sept. 29, 2020 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-...
Read more

Paris, France, September 28, 2020, 7:30 am CEST – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing...
Read more

Uppsala, Sweden – September 25, 2020 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today invites investors, analysts, and media to attend a teleconference on Thursday Octobe...
Read more

Gothenburg, September 25, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announc...
Read more

PARIS, France and NEW YORK, N.Y.—September 23, 2020— Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing treatments for inhe...
Read more

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AN...
Read more

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AN...
Read more

September 22, 2020 Trinity Health employees who may be struggling to manage stress related to the coronavirus pandemic now have new tools available to help them cope. Trini...
Read more

New corporate identity to better reflect the company’s advanced stage IND approval allows initiation of Phase I/II clinical trial with lead compound CAM-H2 in advanced/metasta...
Read more